Loading...
Loading...
In the last 30-day frame, the company witnessed two positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.
Sequenom currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include Cambrex Corporation. CBM, Alkermes plc ALKS and Alexion Pharmaceuticals, Inc. ALXN. While Alexion and Alkermes sport a Zacks Rank #1 (Strong Buy), Cambrex carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ALEXION PHARMA ALXN: Free Stock Analysis Report
CAMBREX CORP CBM: Free Stock Analysis Report
SEQUENOM INC SQNM: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in